Introduction. Nontuberculous mycobacteria (NTM) are environmental mycobacteria which may cause pulmonary and extrapulmonary diseases. These organisms are difficult to treat due to their intrinsic drug-resistance. In Italy, no major nationwide study on NTM epidemiology and drug susceptibility was performed. Methods. Data on the epidemiology of 7,469 NTM clinical isolates identified in Italy in 2016-2020 and on the minimum inhibitory concentrations (MICs) of 1,506 of these strains were analysed. Results. Overall, 63 species were identified in 42 hospital laboratories located in 16 out of 20 regions, with Mycobacterium avium complex (MAC) being the most frequently iso-lated, followed by M. gordonae, M. xenopi, M. abscessus. The MICs of 12 drugs for MAC, M. xenopi, M. kansasii, M. abscessus, M. fortuitum and M. chelonae were interpreted for clinical significance (susceptible, intermediate, resistant) based on the guidelines pub-lished by the Clinical and Laboratory Standards Institute in November 2018. Conclusions. Our data are in line with other nationwide studies and may be of value for further update of microbiological and clinical guidelines.

Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020

Rindi, L;
2023-01-01

Abstract

Introduction. Nontuberculous mycobacteria (NTM) are environmental mycobacteria which may cause pulmonary and extrapulmonary diseases. These organisms are difficult to treat due to their intrinsic drug-resistance. In Italy, no major nationwide study on NTM epidemiology and drug susceptibility was performed. Methods. Data on the epidemiology of 7,469 NTM clinical isolates identified in Italy in 2016-2020 and on the minimum inhibitory concentrations (MICs) of 1,506 of these strains were analysed. Results. Overall, 63 species were identified in 42 hospital laboratories located in 16 out of 20 regions, with Mycobacterium avium complex (MAC) being the most frequently iso-lated, followed by M. gordonae, M. xenopi, M. abscessus. The MICs of 12 drugs for MAC, M. xenopi, M. kansasii, M. abscessus, M. fortuitum and M. chelonae were interpreted for clinical significance (susceptible, intermediate, resistant) based on the guidelines pub-lished by the Clinical and Laboratory Standards Institute in November 2018. Conclusions. Our data are in line with other nationwide studies and may be of value for further update of microbiological and clinical guidelines.
2023
Giannoni, F; Lanni, A; Iacobino, A; Fattorini, L; Ghisetti, V; Mondo, A; Curtoni, A; de Renzi, G; Andreoni, S; Camaggi, A; Piana, F; Marchese, A; Mazzola, E; Torri, S; Cichero, P; Gona, F; Carletti, S; Cirillo, Dm; Borroni, E; Lombardi, A; Libanori, E; D’Inzeo, S; Giagulli, C; Paganini, G; Pinsi, G; Monzillo, V; Barbarini, D; Arosio, M; Farina, C; Peracchi, M; di Santolo, M; Busetti, M; Sartor, A; Picierno, A; Pedrotti, C; Frizzera, E; Tomasi, M; Scarparo, C; Fallico, L; Dal Monte, P; Bisognin, F; Pietrosemoli, P; Denicolò, A; Piersimoni, C; Pocognoli, A; Bartolesi, A; Rindi, L; Parisio, Em; Badolato, Mc; Cenci, E; Mencacci, A; Fioriti, D; Parisi, G; Mazzarelli, A; Nisii, C; Sali, M; Russo, C; Gentile, L; Meledandri, M; Del Giudice, A; Ronga, L; Costa, D; Grimaldi, A; De Nittis, R; Rollo, T; Dodaro, S; Greco, F; Nisticò, S; Vinci, M; Di Naso, C; Aste, A; Masala, L
File in questo prodotto:
File Dimensione Formato  
giannoni 2023.pdf

accesso aperto

Licenza: Creative commons
Dimensione 132.92 kB
Formato Adobe PDF
132.92 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1200607
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact